Test Code GALE Uridine Diphosphate-Galactose 4' Epimerase, Blood
Reporting Name
UDP-galactose 4' epimerase, RBCPerforming Laboratory
Mayo Clinic Laboratories in RochesterUseful For
Diagnosis of uridine diphosphate-galactose 4' epimerase deficiency
Method Name
Enzyme Reaction followed by Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS)
Ordering Guidance
This test is appropriate for diagnosis of uridine diphosphate-galactose 4' epimerase (GALE) deficiency, but it will not detect galactokinase (GALK) deficiency, galactose-1-phosphate uridyltransferase (GALT) deficiency, or galactose mutarotase (GALM) deficiency.
-To evaluate for GALK deficiency, order GALK / Galactokinase, Blood.
-To evaluate for GALT deficiency, order GALT / Galactose-1-Phosphate Uridyltransferase, Blood.
-To evaluate for GALM deficiency, order GALP / Galactose, Plasma and molecular analysis of the GALM gene.
This assay is not appropriate for monitoring dietary compliance for patients with GALE deficiency. If dietary monitoring is needed, order GAL1P / Galactose-1-Phosphate, Erythrocytes.
Necessary Information
Patient's age is required.
Biochemical Genetics Patient Information (T602) is recommended, but not required, to be filled out and sent with the specimen to aid in the interpretation of test results.
Specimen Required
Multiple whole blood tests for galactosemia can be performed on 1 specimen. Prioritize order of testing when submitting specimens. For a list of tests that can be ordered together, see Galactosemia-Related Test List.
Container/Tube:
Preferred: Lavender top (EDTA)
Acceptable: Green top (sodium or lithium heparin) or yellow top (ACD)
Specimen Volume: 5 mL
Specimen Type
Whole Blood EDTASpecimen Minimum Volume
2 mL
Specimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Whole Blood EDTA | Refrigerated (preferred) | 14 days | |
Ambient | 6 days |
Reject Due To
Gross hemolysis | Reject |
Reference Values
≥3.5 nmol/h/mg of hemoglobin
Interpretation
Results below 3.5 nmol/h/mg of hemoglobin in properly submitted specimens have different causes from carrier status for a disease-causing variant in the GALE gene (typically reduced uridine diphosphate-galactose 4' epimerase [GALE] activity close to the normal activity range) to generalized epimerase deficiency galactosemia due to biallelic disease-causing variants in the GALE gene that markedly reduce GALE activity. Further differentiation requires additional biochemical and molecular genetic analyses as well as correlation with clinical signs and symptoms.
Normal results (≥3.5 nmol/hour/mg of hemoglobin) are not consistent with galactosemia due to GALE deficiency.
Day(s) Performed
Friday
Report Available
6 to 12 daysTest Classification
This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. It has not been cleared or approved by the US Food and Drug Administration.CPT Code Information
82542
LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
GALE | UDP-galactose 4' epimerase, RBC | 79469-3 |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
64372 | UDP-galactose 4' epimerase, RBC | 79469-3 |
37979 | Interpretation (GALE) | 59462-2 |
37978 | Reviewed By | 18771-6 |
Forms
1. New York Clients-Informed consent is required. Document on the request form or electronic order that a copy is on file. The following documents are available:
-Informed Consent for Genetic Testing (T576)
-Informed Consent for Genetic Testing-Spanish (T826)
2. Biochemical Genetics Patient Information (T602) is recommended.
3. If not ordering electronically, complete, print, and send a Biochemical Genetics Test Request (T798) with the specimen.
Testing Algorithm
For more information see Galactosemia Testing Algorithm.